Combined pharmacologic treatment with clopidogrel and statin for patients with acute coronary syndrome: Is there a survival advantage? [3] (multiple letters)
10.1093/eurheartj/ehi434
Saved in:
Main Authors: | Almsherqi, Z., Deng, Y., Mclachlan, C., Mossop, P.J., Lim, M.J., Mehta, R.H. |
---|---|
其他作者: | PHYSIOLOGY |
格式: | Others |
出版: |
2011
|
在線閱讀: | http://scholarbank.nus.edu.sg/handle/10635/24997 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | National University of Singapore |
相似書籍
-
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
由: Almsherqi, Z.A., et al.
出版: (2011) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
由: Almsherqi, Z.A., et al.
出版: (2016) -
Evaluation of clopidogrel resistance [3]
由: Almsherqi, Z.A., et al.
出版: (2011) -
Interpretation of clopidogrel resistance (multiple letters)
由: Almsherqi, Z.A., et al.
出版: (2016) -
Interpretation of clopidogrel resistance (multiple letters)
由: Almsherqi, Z.A., et al.
出版: (2014)